Avoro Capital Advisors Reduces Its Stake in TRML ($TRML)
Avoro Capital Advisors has fully exited its position in TRML, selling all 2.56 million shares.
Key Points
- Avoro Capital Advisors sold its entire stake of 2.56 million shares in TRML, reflecting a 100% reduction.
- Multiple insiders, including the CBO and Chief Technology Officer, sold shares of TRML on October 28, 2025.
- Several analysts downgraded TRML to a hold rating in September 2025, setting a price target of $48.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Avoro Capital Advisors has completely exited its position in TRML. According to its latest filing with the SEC, the firm sold its entire holding of 2,555,555 shares. This move reflects a 100% reduction from its prior stake.
What Changed in Avoro Capital Advisors' TRML Position
Avoro Capital Advisors had previously held 2,555,555 shares of TRML. As of the latest filing, the firm has sold all its shares, marking a complete exit from the stock. The exact value of the sale wasn't disclosed.
Insider Buying and Selling at TRML
Insider activity at TRML shows significant selling activity on October 28, 2025. Bradford Middlekauff, the Chief Business Officer and General Counsel, sold 60,988 shares. Sapna Srivastava sold 46,800 shares, while Susan Dana Jones, the Chief Technology Officer, sold 3,152 shares. Additionally, Kevin Bruce Johnson, the Chief Regulatory Officer, sold 11,046 shares, and Caley Castelein sold 36,800 shares. These transactions were not part of a pre-planned trading program.
Analysts Set New Price Targets
Several analysts downgraded TRML to a hold rating in September 2025. BMO Capital, Piper Sandler, Truist Securities, Guggenheim, HC Wainwright & Co., and Chardan Capital all set a price target of $48. Meanwhile, Jefferies set its target slightly lower at $47.5. These downgrades suggest a cautious outlook on the stock.
Bottom Line
Avoro Capital Advisors' decision to sell its entire stake in TRML is noteworthy, as it reflects a significant shift in its investment strategy. Insider selling and analyst downgrades further highlight the cautious sentiment surrounding TRML. It's important to remember that 13F filings are backward-looking and may not reflect current positions. Investors often track such filings to gauge institutional sentiment and potential market movements.
Get TRML alerts
New 13F filings, insider trades, and analyst moves on $TRML, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
